Inphact gains $15 million investment from MDSMDS, a Canadian provider of laboratory and clinical services and products, has invested $15 million in Inphact, a Nashville, TN-based firm providing imaging and teleradiology services over the
MDS, a Canadian provider of laboratory and clinical services and products, has invested $15 million in Inphact, a Nashville, TN-based firm providing imaging and teleradiology services over the Internet. The investment is intended to enable MDS to provide Inphact services on an exclusive basis in Canada and to MDS joint-venture facilities in the U.S. Inphact claims to be the first application service provider in the imaging market and is offering its PACS on a subscription basis over an ASP platform. The foundation of the firms platform is RadWeb, which provides browser-based access to radiology images and reports and the ability to manipulate and enhance digital images. Inphact plans to develop its ASP product for other imaging modalities, starting with cardiology.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.